Abstract:This is the first multicenter double-blinded RCT reporting superior short- and long-term cosmetic and body image, postoperative pain, and QoL in SPLC compared with 4PLC. Although cost-effectiveness is still a subject of ongoing debate, SPLC should be offered to patients undergoing surgery for benign gallbladder disease.
“…However, the objective and reproducible evaluation of QOL is not easy, especially in minimally invasive surgery or simple basic surgical procedure. Recently, for cholecystectomy, double-blinded RCT evaluating QOL between singleport cholecystectomy and conventional laparoscopic cholecystectomy was firstly reported (10). Using previously validated cosmesis and body image scores, and short form 36 health survey questionnaire SF-36, this study reported the statistical advantage of cosmesis and body image, higher QOL regarding emotional wellbeing, physical pain, physical health and mental health after postoperative 1 year, and less postoperative pain in single port cholecystectomy (47)(48)(49).…”
Section: Outcome and Understandingmentioning
confidence: 83%
“…In terms of general surgery including appendectomy or cholecystectomy, recent several studies have reported that SILS is feasible and has similar surgical outcome without increasing significant complication (7)(8)(9)(10). In terms of malignancy of digestive tract, SILS has been eagerly investigated in colorectal cancer and showed comparable outcome in a few studies including randomized clinical trial…”
Section: Introduction For Single-incision Laparoscopic Surgery (Sils)mentioning
Based on rapid development of laparoscopic techniques and instruments, single-incision laparoscopic surgery (SILS) is expected to be the next step of "more" minimally invasive surgery. A few institutions gradually started to report their experience of single incision gastrectomy (SIG) for gastric cancer, but it is still difficult to accept that SIG can be performed as a popular procedure because of its technical difficulty. For wide adoption of SIG, the simplicity, safety and reproducibility of not only lymph node dissection but also reconstruction should be evaluated compared to a conventional procedure. With a thorough understanding of unique characteristics of SILS, single incision distal gastrectomy (SIDG) for early gastric cancer performed by laparoscopic surgeons with advanced technique is expected to have promising potential about excellent cosmesis, comparable morbidity and mortality in carefully selected patients. For appropriate adoption and steady progress of this state-of-the art surgery, scientific evaluation with healthy critics is necessary with new generation of SILS instrument platform.
“…However, the objective and reproducible evaluation of QOL is not easy, especially in minimally invasive surgery or simple basic surgical procedure. Recently, for cholecystectomy, double-blinded RCT evaluating QOL between singleport cholecystectomy and conventional laparoscopic cholecystectomy was firstly reported (10). Using previously validated cosmesis and body image scores, and short form 36 health survey questionnaire SF-36, this study reported the statistical advantage of cosmesis and body image, higher QOL regarding emotional wellbeing, physical pain, physical health and mental health after postoperative 1 year, and less postoperative pain in single port cholecystectomy (47)(48)(49).…”
Section: Outcome and Understandingmentioning
confidence: 83%
“…In terms of general surgery including appendectomy or cholecystectomy, recent several studies have reported that SILS is feasible and has similar surgical outcome without increasing significant complication (7)(8)(9)(10). In terms of malignancy of digestive tract, SILS has been eagerly investigated in colorectal cancer and showed comparable outcome in a few studies including randomized clinical trial…”
Section: Introduction For Single-incision Laparoscopic Surgery (Sils)mentioning
Based on rapid development of laparoscopic techniques and instruments, single-incision laparoscopic surgery (SILS) is expected to be the next step of "more" minimally invasive surgery. A few institutions gradually started to report their experience of single incision gastrectomy (SIG) for gastric cancer, but it is still difficult to accept that SIG can be performed as a popular procedure because of its technical difficulty. For wide adoption of SIG, the simplicity, safety and reproducibility of not only lymph node dissection but also reconstruction should be evaluated compared to a conventional procedure. With a thorough understanding of unique characteristics of SILS, single incision distal gastrectomy (SIDG) for early gastric cancer performed by laparoscopic surgeons with advanced technique is expected to have promising potential about excellent cosmesis, comparable morbidity and mortality in carefully selected patients. For appropriate adoption and steady progress of this state-of-the art surgery, scientific evaluation with healthy critics is necessary with new generation of SILS instrument platform.
“…In a recent randomised controlled trial comparing cholecystectomy and intra-operative cholangiogram with endoscopic duct assessment followed by cholecystectomy from the group in Geneva, quality of life was assessed as a secondary endpoint using EuroQol-5D scores [6]. And, quality of life was a secondary endpoint in another recent Swiss study evaluating cosmesis and body image after SILS versus conventional laparoscopic cholecystectomy [13]. …”
BackgroundA number of prominent surgical trials and clinical guidelines regard length of hospital stay and rates of daycase surgery as being of upmost importance following cholecystectomy.
However, it is unclear whether these outcomes also matter to patients. This study aimed to identify the factors patients regard as most important when admitted with acute gallstone pathology.MethodsA 41-item survey was produced by combining outcomes assessed in recent clinical trials with results from a preliminary patient questionnaire. This was then given out prospectively to patients presenting with acute gallstone pathology, prior to their cholecystectomy. Patients were asked to read an information sheet about laparoscopic cholecystectomy and then complete the survey, scoring each item out of 100 in terms of importance to them.ResultsFifty-six patients completed the survey (43 females; median age 51 years). Diagnoses were: cholecystitis (28 patients), biliary colic (13), pancreatitis (10), common bile duct stones (3) and cholangitis (2). The top-scoring survey item was “long-term quality of life after surgery”, with a median value of 97 out of 100. Other high-scoring items included “cleanliness of the ward environment” and “pain control after surgery” (both 96). The lowest-scoring item was “being treated as a daycase” (54).ConclusionPatients with acute gallstone pathology view long-term quality of life after surgery as the most important factor and daycase surgery as the least important. These results should be considered when planning future surgical trials and clinical guidelines.Electronic supplementary materialThe online version of this article (doi:10.1007/s00268-016-3854-x) contains supplementary material, which is available to authorized users.
“…4 After the introduction of this new technique, more than a dozen randomized clinical trials were conducted to compare SILC with 4PLC. [5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20] These trials were designed to focus on cosmesis, pain, or quality of life (QOL), with patient-reported outcomes to evaluate subjectively the degree of patient suffering. In particular, QOL is drawing attention as a key measure to understand how patients evaluate their physical, mental, or social health status.…”
Background: Controversy continues as to whether single-incision laparoscopic cholecystectomy, with the somewhat larger incision at the umbilicus, may lead to a worse postoperative quality of life and more pain compared with the more classic 4-port laparoscopic cholecystectomy. The aim of this study was to compare single-incision and 4-port laparoscopic cholecystectomy from the perspective of quality of life. Methods: This study was a multicenter, parallel-group, open-label, randomized clinical trial. A total of 120 patients who were scheduled to undergo elective cholecystectomy were randomly assigned 1:1 into the single-incision laparoscopic cholecystectomy or the 4-port laparoscopic cholecystectomy group and then assessed continuously for 2 weeks during the postoperative period. The primary outcome was quality of life, defined as the time to resume normal daily activities. Postoperative pain was also assessed. To explore the heterogeneity of treatment effects, we assessed the interactions of sex, age, and working status on recovery time. Results: A total of 58 patients in the single-incision group and 53 in the 4-port group (n = 111, 47 male, mean age 57 years) were analyzed. The mean time to resume daily activities was 10.2 days and 8.8 days, respectively, for single-incision and 4-port laparoscopic cholecystectomy (95% confidence interval-0.4 to 3.2, P = .12). Similarly, the time to relief from postoperative pain did not differ significantly between the groups. Statistically insignificant but qualitative interactions were noted; in the subgroups of women, full-time workers, and patients younger than 60 years, recovery tended to be slower after single-incision laparoscopic cholecystectomy. Conclusion: Postoperative quality of life did not differ substantially between single-incision laparoscopic cholecystectomy and 4-port laparoscopic cholecystectomy. Patients younger than 60 years, women, and full-time workers tended to have a somewhat slower recovery after single-incision laparoscopic cholecystectomy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.